Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
allele, aspect, ATM, Boehringer, categorically, conjugate, ctDNA, daily, driver, EGFR, enjoined, epidermal, fatigue, gastrointestinal, harboring, Hengrui, home, Ingelheim, intracranial, inventor, median, mg, mm, newest, Notably, Objective, passage, periphery, poziotinib, PRs, pyrotinib, QD, ransomware, rash, RECIST, sequential, Shanghai, shrinkage, side, skin, Spectrum, TRAE, unpatented, wild
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view